Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

WHO 2022 classification of penile and scrotal cancers: updates and evolution (2022) Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Comperat E, et al. Journal article Early CRP kinetics predict long-term treatment success and favorable outcomes of anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma (2022) Klümper N, Sikic D, Saal J, Buettner T, Jarczyk J, Zeuschner P, Weinke M, et al. Conference contribution Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster A prospective, open-label, multicenter, randomized phase II trial: Sequential therapy with BEvacizumab, RAd001 (Everolimus) and AxiTinib in metastatic renal cell carcinoma (mRCC) (BERAT study of the IAG-N) (2022) Hilser T, Gruenwald V, Bergmann L, Goebell P, Strauss A, Meiler J, Hartmann A, et al. Conference contribution Clinical and histopathological characterization of penile carcinomas with focus on HPV-status and histological subtype (2022) Mink J, Khalmurzaev O, Hoelters S, Pryalukhin A, Heinzelbecker J, Lohse S, Bende K, et al. Conference contribution Expression of disialoganglioside GD2 in breast cancer subtypes (2022) Gaß P, Kailayangiri S, Hübner H, Rübner M, Hartmann A, Häberle L, Völkl S, et al. Conference contribution Distinct mircobiomes in right- and left-sided colon cancer (2022) Langheinrich MC, Wirtz S, Kneis B, Weber K, Brunner M, Krautz C, Trebicka J, et al. Conference contribution Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients (2022) Lieb V, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, Bellut L, et al. Journal article Induction of pulmonary HLA-G expression by SARS-CoV-2 infection (2022) Seliger B, Jasinski-Bergner S, Massa C, Mueller A, Biehl K, Yang B, Bachmann M, et al. Journal article Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma (2022) Kloker LD, Calukovic B, Benzler K, Golf A, Böhm S, Günther S, Horger M, et al. Journal article